Stock Day Media

Silo Pharma Inc. Receives One Million Dollars in Up Front Licensing Deal for its Psilocybin Cancer Therapeutic Applications in a Combination of Cash and Equities

Englewood Cliffs, NJ, Jan. 06, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on

COVID-19 clinical trial planned for Q1 2021 supported by Canadian Government Proof of concept would validate platform for multiple indications

TORONTO, ON., (Uptick Newswire – Jun 26, 2017) – Easton Pharmaceuticals, Inc. (OTC: EAPH), is pleased to announce it has

January 22, 2021 Stock Day Media Comments Off

Over the past two decades, online shopping has become increasingly popular among people of all ages. Many people now go